Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,617.23
1,673.53
1,684.82
1,582.78
1,464.55
1,624.21
1,824.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,617.23
1,673.53
1,684.82
1,582.78
1,464.55
1,624.21
1,824.25
Raw Material Cost
745.50
826.08
794.97
806.69
742.82
804.03
815.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.95
1.75
2.33
1.36
4.88
6.36
8.19
Selling and Distribution Expenses
636.63
617.57
648.77
553.56
539.71
601.64
699.91
Other Expenses
6.20
5.93
4.31
8.43
6.37
5.92
4.26
Total Expenditure (Excl Depreciation)
1,446.05
1,504.73
1,489.14
1,445.87
1,351.08
1,471.22
1,566.25
Operating Profit (PBDIT) excl Other Income
171.20000000000002
168.79999999999998
195.7
136.9
113.5
153
258
Other Income
23.25
26.00
20.97
22.33
29.56
63.81
37.23
Operating Profit (PBDIT)
174.19
254.21
277.09
207.93
218.46
287.55
344.38
Interest
1.95
1.75
2.33
1.36
4.88
6.36
8.19
Exceptional Items
79.83
16.08
18.88
6.60
25.87
-4.84
2.64
Gross Profit (PBDT)
871.74
847.45
889.85
776.09
721.74
820.18
1,008.72
Depreciation
0.00
87.14
87.14
90.89
90.89
86.11
86.11
Profit Before Tax
252.07
181.40
206.50
122.27
148.55
190.26
252.73
Tax
33.61
35.00
31.96
20.07
26.35
35.74
39.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
230.43
164.21
189.40
103.96
136.26
166.14
216.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
230.43
164.21
189.40
103.96
136.26
166.14
216.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.20
4.32
3.62
8.21
2.37
11.46
13.90
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
234.63
168.53
193.02
112.17
138.63
177.59
229.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,061.63
6,814.58
7,017.95
6,819.71
6,654.67
6,675.63
7,144.53
Earnings per share (EPS)
0.09
0.07
0.06
0.04
0.05
0.06
0.08
Diluted Earnings per share
0.09
0.07
0.06
0.04
0.05
0.06
0.08
Operating Profit Margin (Excl OI)
9.33%
8.43%
10.03%
5.98%
6.69%
8.47%
12.12%
Gross Profit Margin
15.59%
16.05%
17.43%
13.47%
16.35%
17.02%
18.57%
PAT Margin
14.25%
9.81%
11.24%
6.57%
9.3%
10.23%
11.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.36% vs -0.67% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 39.23% vs -12.69% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -33.87% vs -10.89% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 11.76% vs -26.09% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Zhejiang Conba Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,617.23
0
1,617.23
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,617.23
0
1,617.23
Raw Material Cost
745.50
0
745.50
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.95
0
1.95
Selling and Distribution Expenses
636.63
0
636.63
Other Expenses
6.20
0.00
6.20
Total Expenditure (Excl Depreciation)
1,446.05
0
1,446.05
Operating Profit (PBDIT) excl Other Income
171.19
0.00
171.19
Other Income
23.25
0
23.25
Operating Profit (PBDIT)
174.19
0
174.19
Interest
1.95
0
1.95
Exceptional Items
79.83
0
79.83
Gross Profit (PBDT)
871.74
0
871.74
Depreciation
0.00
0
0.00
Profit Before Tax
252.07
0
252.07
Tax
33.61
0
33.61
Provisions and contingencies
0
0
0.00
Profit After Tax
230.43
0
230.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
230.43
0
230.43
Share in Profit of Associates
0
0
0.00
Minority Interest
4.20
0
4.20
Other related items
0.00
0.00
0.00
Consolidated Net Profit
234.63
0
234.63
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,061.63
0
7,061.63
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
9.33%
0%
0.00
9.33%
Gross Profit Margin
15.59%
0%
0.00
15.59%
PAT Margin
14.25%
0%
0.00
14.25%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 161.72 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -3.36% vs -0.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 10.42% vs 3.16% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.46 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 39.23% vs -12.69% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 69.26% vs 11.59% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.09 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -33.87% vs -10.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -20.12% vs -10.22% in Sep 2024
Quarterly - Interest
Interest 0.19 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 11.76% vs -26.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -61.22% vs -49.48% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.33%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
